On-Demand DCT Webinars

31. Everything You Need To Know About Adopting eConsent Across Large Pharma Organizations 2/22/2023

    Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.

32. Decentralized Trial Solutions For Complex Clinical Trials: Webinar Replay 2/21/2023

    Most complex studies are considered challenging, but not impossible. Learn from a collective of experts on how to create successful decentralized clinical trials.

33. Complex DCT Delivery: What Is Possible Outside Of A Site? 1/18/2023

    Todd McGrath, Chief Operating Officer, and Emily McDougal, Executive Director of Nurse Management, show how the decentralized delivery of complex clinical visits can benefit studies, sites, and patients.

34. Mastering The Virtual Clinical Trial 1/12/2023

    In a virtual clinical trial, patients forgo many site visits. Hear from executives with expertise in R&D and technology implementation explain the potential benefits of virtual clinical trials.

35. Designing ePRO and eConsent Solutions that Participants and Sites Want 10/26/2022

    Participant-focused eClinical technologies offer significant potential to decrease paper-based processes and improve end-user experiences in collecting patient-reported outcomes (PRO) and informed consent, but many users continue to experience rigid technology, complicated hardware provisioning processes, and clunky implementations that leave sponsors, CROs and sites questioning the value. 

36. DCT Is Not The Goal, Just The Means 10/20/2022

    Learn more about the role of DCTs with a deep dive in an oncology case study as well as a pediatric case study, discussing the role of flexibility to support the DCT format.

37. Improving Patient & Sponsor Confidence In Decentralized Clinical Trials 10/18/2022

    Speakers debunk common myths associated with data collection approaches using technology while highlighting strategies to improve the patient experience, without compromising quality, speed, or cost.

38. The Platform Shift is Here: Are you Realizing ROI Across your Portfolio of Studies? 9/20/2022

    Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.

39. Clinical Trials From Home: The Role Of Research Nurses 8/26/2022

    In this presentation, speakers shed light on the advantages of home visits for clinical trials and what research nurses do to make this possible.

40. Applying The Lessons Of The Pandemic To Your Upcoming Trial 8/26/2022

    In this webinar featuring Ellen Weiss, vice president of in-home solutions for EmVenio Clinical Research, learn how the pandemic has impacted the industry and what it means for CROs and sponsors now and moving forward.